MEMBER PRESS RELEASE: Atterocor Launches Innovative Company Focused on Accelerated Development of Treatment for Adrenal Cancer; Secures $16 Million Series A Financing Life Sciences Investors Frazier Healthcare and 5AM Ventures Lead the Round Ann Arbor, Michigan – August 3, 2012 – Atterocor, Inc., a company developing an innovative therapy for adrenal cancer, today announced a […]